Literature DB >> 1673762

Compliance and clinical trials.

J Urquhart.   

Abstract

Mesh：

Year:  1991        PMID： 1673762     DOI： 10.1016/0140-6736(91)92896-a

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Age-specific nonpersistence of endocrine therapy in postmenopausal patients diagnosed with hormone receptor-positive breast cancer: a TEAM study analysis.

Authors:  Willemien van de Water; Esther Bastiaannet; Elysée T M Hille; Elma M Meershoek-Klein Kranenbarg; Hein Putter; Caroline M Seynaeve; Robert Paridaens; Anton J M de Craen; Rudi G J Westendorp; Gerrit-Jan Liefers; Cornelis J H van de Velde
Journal:  Oncologist       Date:  2011-12-30

2.  Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer.

Authors:  E L Mayer; A H Partridge; L N Harris; R S Gelman; S T Schumer; H J Burstein; E P Winer
Journal:  Breast Cancer Res Treat       Date:  2009-03-18       Impact factor: 4.872

3.  Performance of Cpred/Cobs concentration ratios as a metric reflecting adherence to antidepressant drug therapy.

Authors:  Yan Feng; Marc R Gastonguay; Bruce G Pollock; Ellen Frank; Gail H Kepple; Robert R Bies
Journal:  Neuropsychiatr Dis Treat       Date:  2011-03-17       Impact factor: 2.570

4.  Adolescents and young adults with cancer: aspects of adherence - a questionnaire study.

Authors:  Anne Marie Kleinke; Carl Friedrich Classen
Journal:  Adolesc Health Med Ther       Date:  2018-05-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.